What did the trial find about multivitamins and aging?

Multivitamins slightly slow some aging markers in older adults

A randomized clinical trial found that daily use of a combined multivitamin–multimineral supplement was associated with a small reduction in some DNA-based markers of biological aging in older adults.

The study’s key point is modest but important for how researchers and consumers interpret “healthy aging” interventions. Instead of claiming major improvements in lifespan or fully reversing age-related decline, the trial focused on molecular indicators—specifically DNA-based measures often used as proxies for biological aging.

What happened

• Participants were assigned to take a daily multivitamin–multimineral supplement or a control condition.
• Over the course of the trial, the supplement group showed slight slowing in at least some of the measured DNA-based aging markers.

Why it matters

• Mechanistic relevance: DNA-based biological aging markers can reflect cellular processes that change with time, inflammation, and damage.
• Real-world framing: The effect was described as slight, which suggests multivitamins are unlikely to be a standalone “anti-aging” solution.
• Evidence for biomarkers: Trials like this help clarify whether inexpensive, widely used supplements meaningfully shift measurable aging-related biology.

The story doesn’t specify the supplement brand, the magnitude of change across all markers, or whether clinical outcomes (like disease incidence) were improved. Still, it provides a clearer, trial-based picture than anecdotal claims by linking supplement use to measurable shifts in biological aging signals.

Overall, the findings support the idea that multivitamins may affect certain aging-related molecular pathways—while also underscoring that the benefits observed are limited.